Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Regeneron Pharmaceuticals Inc (REGN)  
$985.02 4.45 (0.45%) as of 4:30 Fri 5/24


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 104,690,000
Market Cap: 103.12(B)
Last Volume: 259,279 Avg Vol: 765,410
52 Week Range: $692.45 - $993.95
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     S&P SMALLCAP 600
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  150
Guru Rank Value     : 6.9
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Regeneron Pharmaceuticals is a biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. Co.'s products include: EYLEA (aflibercept) Injection, which is used for the treatment of neovascular age-related macular degeneration, diabetic macular edema, macular edema following retinal vein occlusion, myopic choroidal neovascularization, diabetic retinopathy, and neovascular glaucoma; REGEN-COV, which is used for the treatment of COVID-19; and Kevzara (sarilumab) Solution for Subcutaneous Injection, which is used for the treatment of rheumatoid arthritis.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 168,566 236,471 279,472 438,206
Total Sell Value $164,437,486 $226,505,895 $262,153,799 $373,147,368
Total People Sold 8 14 16 18
Total Sell Transactions 15 42 60 120
End Date 2024-02-25 2023-11-24 2023-05-26 2022-05-26

   
Records found: 1366
  Page 30 of 55  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Ryan Arthur F Director   –       •      –    2020-05-06 4 GD $0.00 $0 D/D 2,000 24,343     -
   Van Plew Daniel P EVP & General Mgr Industrial O   •       –      –    2020-05-06 4 D $555.77 $25,563,197 D/D (45,996) 67,834     -
   Van Plew Daniel P EVP & General Mgr Industrial O   •       –      –    2020-05-06 4 OE $52.03 $4,452,675 D/D 85,579 96,051     -
   Tessier-Lavigne Marc Director   –       •      –    2020-05-06 4 S $562.65 $8,459,496 D/D (15,000) 1,830 -5%     
   Tessier-Lavigne Marc Director   –       •      –    2020-05-06 4 OE $177.82 $2,667,300 D/D 15,000 16,830     -
   Brown Michael S Director   –       •      –    2020-05-06 4 D $555.77 $2,034,674 D/D (3,661) 2,452     -
   Brown Michael S Director   –       •      –    2020-05-06 4 OE $273.67 $2,034,739 D/D 5,470 2,575     -
   Ryan Arthur F Director   –       •      –    2020-05-06 4 S $541.66 $27,612,509 D/D (50,124) 28,843 -5%     
   Ryan Arthur F Director   –       •      –    2020-05-06 4 OE $177.82 $18,729,670 D/D 50,124 78,967     -
   Goldstein Joseph L Director   –       •      –    2020-05-06 4 S $560.00 $1,120,000 D/D (2,000) 7,643 -5%     
   Ryan Arthur F Director   –       •      –    2020-05-01 4 AS $517.41 $52,037 D/D (100) 28,843 4%     
   Larosa Joseph J EVP General Counsel and Secret   •       –      –    2020-04-20 4 AS $561.57 $1,991,611 D/D (3,522) 16,216 6%     
   Landry Robert E EVP Finance CFO   •       –      –    2020-04-20 4 AS $562.71 $1,842,539 D/D (3,250) 24,373 6%     
   Larosa Joseph J EVP General Counsel and Secret   •       –      –    2020-04-20 4 AS $567.30 $1,013,985 D/D (1,778) 14,438 6%     
   Larosa Joseph J EVP General Counsel and Secret   •       –      –    2020-04-17 4 D $555.82 $3,513,894 D/D (6,322) 19,738     -
   Larosa Joseph J EVP General Counsel and Secret   •       –      –    2020-04-17 4 OE $59.20 $688,022 D/D 11,622 22,458     -
   Larosa Joseph J EVP General Counsel and Secret   •       –      –    2020-04-17 4 AS $541.94 $1,263,586 D/D (2,267) 14,438 8%     
   Landry Robert E EVP Finance CFO   •       –      –    2020-04-17 4 D $555.82 $5,141,335 D/D (9,250) 27,623     -
   Landry Robert E EVP Finance CFO   •       –      –    2020-04-17 4 OE $272.70 $3,408,750 D/D 12,500 36,873     -
   Landry Robert E EVP Finance CFO   •       –      –    2020-04-17 4 AS $540.70 $552,661 D/D (991) 24,373 8%     
   Larosa Joseph J EVP General Counsel and Secret   •       –      –    2020-04-16 4 D $529.79 $1,447,916 D/D (2,733) 16,705     -
   Larosa Joseph J EVP General Counsel and Secret   •       –      –    2020-04-16 4 OE $59.20 $296,000 D/D 5,000 19,438     -
   Landry Robert E EVP Finance CFO   •       –      –    2020-04-16 4 D $529.79 $1,594,138 D/D (3,009) 25,364     -
   Landry Robert E EVP Finance CFO   •       –      –    2020-04-16 4 OE $272.70 $1,090,800 D/D 4,000 28,373     -
   Landry Robert E EVP Finance CFO   •       –      –    2020-04-15 4 AS $516.89 $442,276 D/D (853) 24,373 16%     
  1366 Records found
  Previous  30  31  32  33  34  35  36  37  38  39  Next   
  Page 30 of 55
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us